期刊
NATURE REVIEWS CANCER
卷 15, 期 7, 页码 440-448出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3949
关键词
-
类别
资金
- US National Institutes of Health [CA157996]
- Cancer Prevention and Research Institute of Texas [RP130272]
- European research program [CIG618113, ERC614204]
- Israel Science Foundation [1343/13, 1952/13]
- Minerva grant award [711730]
- Adelis Foundation
- Henry S. and Anne S. Reich Research Fund
- Dukler Fund for Cancer Research
- Paul Sparr Foundation
- Saul and Theresa Esman Foundation
- estate of Fannie Sherr
Cancer is a prime example of a disease process in which carcinogenic and metabolic changes are intertwined to promote cell survival and growth. One approach to unravel this complex relationship is by studying rare, monogenic disorders caused by mutations in genes encoding metabolic enzymes or regulators. There are hundreds of these diseases, most of which manifest in childhood and are collectively termed 'inborn errors of metabolism' (IEMs). Several IEMs demonstrate the consequences of chronic, systemic loss of a particular metabolic activity that can result in malignancy. In this Opinion article, we present a conceptual categorization of IEMs associated with cancer and discuss how assessment of these rare diseases might inform us about the biological foundations of common types of cancer and opportunities for cancer diagnosis and therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据